Posts found in:

Ryan Ivey

KO Client Column Acquires Modulist Image

KO Client Column Acquires Modulist

KO client Column Software, the fastest-growing public notice software platform, recently announced that it reached an agreement with Forum Communications in late 2023 to acquire Modulist, a software company focused on celebrations, obituaries, and announcements. Column has deployed its software platform across more than 500 newspapers and publications to facilitate…

KO Client Big Compass Joins Argano Image

KO Client Big Compass Joins Argano

KO client Big Compass, a multi-technology consulting company specializing in data agility, recently joined Argano, a global leader in digital transformation and business consulting, focused on integrating, automating, and optimizing client operations. According to the press release, “Big Compass’ expertise in integrating data for process automation and analytics is a…

Highline Sciences Acquired by Tempus Image

Highline Sciences Acquired by Tempus

KO client Highline Sciences, a specialized, full-service clinical contract research organization (CRO) focused on oncology, has been acquired by Tempus. The KO team, led by attorneys Samantha Pjesky, Jon Taylor and Ryan Ivey, represented Highline in this acquisition. Tempus is a leader in artificial intelligence and precision medicine. With this…

Five Questions with KO’s New Attorneys Image

Five Questions with KO’s New Attorneys

KO Law Firm is growing again. In recent months, the firm has expanded our practice with the addition of new attorneys Logan DeSouza, Robert Donald, Charu Ganesh, Ryan Ivey and Kyle Pawlak. Not only are these additions high-caliber attorneys with a breadth of experience — they also bring unique, diverse experiences…

Addressing CRO Consolidation Risks: How to Protect Clinical Trials Image

Addressing CRO Consolidation Risks: How to Protect Clinical Trials

Contract Research Organization (CRO) consolidation has become a constant force in the life sciences market. This shifting environment has made protecting clinical trial success and anticipating and planning for CRO consolidation risks critical for pharmaceutical and medical device companies when negotiating agreements. Working with high-performing CROs, with deep industry and…